Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma

Mark Hew, Pankaj Bhavsar, Alfons Torrego, Sally Meah, Nadia Khorasani, Peter J. Barnes, Ian Adcock, Fan Chung Kian

Research output: Contribution to journalArticleResearchpeer-review

213 Citations (Scopus)

Abstract

Rationale and Objectives: Patients with severe asthma have a poor therapeutic response to corticosteroid therapy, and corticosteroid responsiveness cannot be easily measured in these patients. We hypothesized that this poor response is associated with a reduced effect of corticosteroids to inhibit cytokine release from activated peripheral blood mononuclear cells (PBMCs). Methods: Patients with severe asthma were defined by American Thoracic Society criteria. We compared the suppression of LPS-induced cytokine release (monocyte chemotactic protein-1 [MCP-1], macrophage inflammatory protein [MIP] 1α, RANTES, tumor necrosis factor α, interleukin 1β (IL-1β), IL-8, IFN-γ, IL-6, IL-10, and granulocyte-macrophage colony-stimulating factor [GM-CSF]) by dexamethasone from PBMCs of patients with severe asthma (n = 16), patients with nonsevere asthma (n = 19), and normal volunteers (n = 10). Results: There was no difference in baseline spontaneous or stimulated release of these cytokines among groups. LPS-induced release of 10 cytokines was less suppressed by dexamethasone (10-6 M) in patients with severe asthma compared with patients with nonsevere asthma, with statistical significance achieved for IL-1β (p < 0.03), IL-8 (p < 0.03), and MIP-1α (p < 0.003), and borderline significance for IL-6 (p = 0.054). There was less difference between the two groups for dexamethasone at 10-8 M. Nuclear histone deacetylase (HDAC) and histone acetyltransferase activities were reduced in patients with severe asthma compared with patients with nonsevere asthma (p < 0.01). HDAC activity reduction correlated directly to the degree of steroid insensitivity of GM-CSF (r = 0.57, p < 0.01) and IFN-γ (r = 0.56, p < 0.05) release. Reduction in histone acetyltransferase activity related to corticosteroid use rather than asthma severity. Conclusions: Patients with severe asthma have diminished corticosteroid sensitivity of PBMCs when compared with patients with nonsevere asthma, associated with a reduction in HDAC activity that parallels the impaired corticosteroid sensitivity.

Original languageEnglish
Pages (from-to)134-141
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume174
Issue number2
DOIs
Publication statusPublished - 13 Jul 2006
Externally publishedYes

Keywords

  • Corticosteroids
  • Histone acetyltransferase
  • Histone deacetylase
  • Severe asthma

Cite this